Caxton Associates LLP Makes New $1.84 Million Investment in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Caxton Associates LLP has made a new investment in Sabra Healthcare REIT, Inc., purchasing 105,103 shares valued at approximately $1.84 million.
• Sabra Healthcare REIT reported a quarterly earnings per share of $0.38, beating analyst expectations, with revenue reaching $189.15 million, representing a year-over-year increase of 7.4%.
• The company declared a quarterly dividend of $0.30 per share, resulting in an annualized yield of 6.3%, despite a high dividend payout ratio of 157.89%.

Caxton Associates LLP bought a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 105,103 shares of the real estate investment trust's stock, valued at approximately $1,836,000.

Other hedge funds also recently bought and sold shares of the company. SVB Wealth LLC purchased a new position in Sabra Healthcare REIT during the first quarter worth about $34,000. UMB Bank n.a. boosted its stake in Sabra Healthcare REIT by 379.6% during the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after buying an additional 1,621 shares during the period. Wealth Preservation Advisors LLC purchased a new position in Sabra Healthcare REIT during the first quarter worth about $38,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Sabra Healthcare REIT by 61.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock worth $49,000 after purchasing an additional 1,065 shares in the last quarter. Finally, Assetmark Inc. lifted its position in shares of Sabra Healthcare REIT by 37.8% during the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after purchasing an additional 989 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Up 0.8%

SBRA stock opened at $19.19 on Tuesday. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The company's 50 day moving average is $18.64 and its two-hundred day moving average is $17.91. The stock has a market cap of $4.60 billion, a P/E ratio of 25.25, a PEG ratio of 1.52 and a beta of 0.88.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. During the same quarter last year, the company earned $0.36 earnings per share. The firm's revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 157.89%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on SBRA shares. Scotiabank increased their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. Truist Financial increased their price target on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a research report on Tuesday, September 2nd. BMO Capital Markets increased their price target on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday, August 25th. Wells Fargo & Company increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. Finally, JMP Securities raised their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.